Literature DB >> 23966505

Impact of blood volume, tube shaking, and incubation time on reproducibility of QuantiFERON-TB gold in-tube assay.

Rajiv L Gaur1, Madhukar Pai, Niaz Banaei.   

Abstract

Gamma interferon (IFN-γ) release assays (IGRAs) are functional assays used serially to measure the efficacy of novel tuberculosis (TB) vaccines and to screen health care workers for latent tuberculosis infection (LTBI). However, studies have shown nonreproducible IGRA results. In this study, we investigated the effects of blood volume (0.8, 1.0, and 1.2 ml), tube shaking (gentle versus vigorous), and incubation duration (16, 20, and 24 h) on the reproducibility of QuantiFERON-TB Gold In-Tube (QFT-GIT) results for 50 subjects (33 uninfected and 17 infected). The median IFN-γ TB response (TB antigen [Ag] minus nil value) was significantly higher with 0.8 ml blood (1.04 IU/ml) than with 1.0 ml (0.85 IU/ml; P = 0.002) or 1.2 ml (0.49 IU/ml; P < 0.001) for subjects with LTBI. Compared with 0.8 ml (11.8%), there were larger proportions of false-negative results with 1.0 ml (29.4%; P = 0.2) and 1.2 ml (41.2%; P = 0.05) of blood for infected subjects. Blood volume did not significantly change the proportions of positive results in uninfected controls. Compared with gentle shaking, vigorous shaking increased the median IFN-γ response in nil (0.04 versus 0.06 IU/ml; P < 0.001) and TB Ag (0.12 versus 0.24 IU/ml; P = 0.004) tubes and increased TB responses (TB Agvigorous minus nilgentle) (0.02 versus 0.08 IU/ml; P = 0.004). The duration of incubation did not have a significant impact on the proportion of positive results in uninfected or infected subjects. This study identified blood volume and tube shaking as novel preanalytical sources of variability which require further standardization in order to improve the quality and reproducibility of QFT-GIT results.

Entities:  

Mesh:

Year:  2013        PMID: 23966505      PMCID: PMC3889728          DOI: 10.1128/JCM.01627-13

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  27 in total

1.  Interferon-gamma release assays for screening of health care workers in low tuberculosis incidence settings: dynamic patterns and interpretational challenges.

Authors:  Madkuhar Pai; Kevin Elwood
Journal:  Can Respir J       Date:  2012 Mar-Apr       Impact factor: 2.409

2.  Immediate incubation reduces indeterminate results for QuantiFERON-TB Gold in-tube assay.

Authors:  Victor Herrera; Ellen Yeh; Kelly Murphy; Julie Parsonnet; Niaz Banaei
Journal:  J Clin Microbiol       Date:  2010-06-02       Impact factor: 5.948

3.  Evaluation of QuantiFERON microtube, using 0.9 mL blood, for diagnosing tuberculosis infection.

Authors:  Michala V Rose; Godfather Kimaro; Inge Kroidl; Michael Hoelscher; Ib C Bygbjerg; Sayoki M Mfinanga; Pernille Ravn
Journal:  Eur Respir J       Date:  2012-08-09       Impact factor: 16.671

4.  Preanalytical delay reduces sensitivity of QuantiFERON-TB gold in-tube assay for detection of latent tuberculosis infection.

Authors:  David Doberne; Rajiv L Gaur; Niaz Banaei
Journal:  J Clin Microbiol       Date:  2011-06-22       Impact factor: 5.948

Review 5.  Evidence-based comparison of commercial interferon-gamma release assays for detecting active TB: a metaanalysis.

Authors:  Roland Diel; Robert Loddenkemper; Albert Nienhaus
Journal:  Chest       Date:  2009-12-18       Impact factor: 9.410

6.  Targeted tuberculin testing and treatment of latent tuberculosis infection. American Thoracic Society.

Authors: 
Journal:  MMWR Recomm Rep       Date:  2000-06-09

7.  The MIT D-lab electricity-free PortaTherm™ incubator for remote testing with the QuantiFERON®-TB Gold In-Tube assay.

Authors:  M Dominguez; A Smith; G Luna; M F Brady; J Austin-Breneman; S Lopez; R Yataco; D A J Moore
Journal:  Int J Tuberc Lung Dis       Date:  2010-11       Impact factor: 2.373

8.  The intrinsic transmission dynamics of tuberculosis epidemics.

Authors:  S M Blower; A R McLean; T C Porco; P M Small; P C Hopewell; M A Sanchez; A R Moss
Journal:  Nat Med       Date:  1995-08       Impact factor: 53.440

9.  Indeterminate test results of T-SPOT.TB performed under routine field conditions.

Authors:  P Beffa; A Zellweger; J-P Janssens; P Wrighton-Smith; J-P Zellweger
Journal:  Eur Respir J       Date:  2007-12-05       Impact factor: 16.671

10.  Interferon-gamma release assays for the tuberculosis serial testing of health care workers: a systematic review.

Authors:  Felix C Ringshausen; Anja Schablon; Albert Nienhaus
Journal:  J Occup Med Toxicol       Date:  2012-06-18       Impact factor: 2.646

View more
  19 in total

1.  Optimization and Interpretation of Serial QuantiFERON Testing to Measure Acquisition of Mycobacterium tuberculosis Infection.

Authors:  Elisa Nemes; Virginie Rozot; Hennie Geldenhuys; Nicole Bilek; Simbarashe Mabwe; Deborah Abrahams; Lebohang Makhethe; Mzwandile Erasmus; Alana Keyser; Asma Toefy; Yolundi Cloete; Frances Ratangee; Thomas Blauenfeldt; Morten Ruhwald; Gerhard Walzl; Bronwyn Smith; Andre G Loxton; Willem A Hanekom; Jason R Andrews; Maria D Lempicki; Ruth Ellis; Ann M Ginsberg; Mark Hatherill; Thomas J Scriba
Journal:  Am J Respir Crit Care Med       Date:  2017-09-01       Impact factor: 21.405

2.  The dynamics of QuantiFERON-TB gold in-tube conversion and reversion in a cohort of South African adolescents.

Authors:  Jason R Andrews; Mark Hatherill; Hassan Mahomed; Willem A Hanekom; Monica Campo; Thomas R Hawn; Robin Wood; Thomas J Scriba
Journal:  Am J Respir Crit Care Med       Date:  2015-03-01       Impact factor: 21.405

3.  Evaluation of Standard E TB-Feron Enzyme-Linked Immunosorbent Assay for Diagnosis of Latent Tuberculosis Infection in Health Care Workers.

Authors:  Oh Joo Kweon; Yong Kwan Lim; Hye Ryoun Kim; Tae-Hyoung Kim; Mi-Kyung Lee
Journal:  J Clin Microbiol       Date:  2019-11-22       Impact factor: 5.948

Review 4.  Reproducibility of interferon gamma (IFN-γ) release Assays. A systematic review.

Authors:  Saloua Tagmouti; Madeline Slater; Andrea Benedetti; Sandra V Kik; Niaz Banaei; Adithya Cattamanchi; John Metcalfe; David Dowdy; Richard van Zyl Smit; Nandini Dendukuri; Madhukar Pai; Claudia Denkinger
Journal:  Ann Am Thorac Soc       Date:  2014-10

Review 5.  Gamma interferon release assays for detection of Mycobacterium tuberculosis infection.

Authors:  Madhukar Pai; Claudia M Denkinger; Sandra V Kik; Molebogeng X Rangaka; Alice Zwerling; Olivia Oxlade; John Z Metcalfe; Adithya Cattamanchi; David W Dowdy; Keertan Dheda; Niaz Banaei
Journal:  Clin Microbiol Rev       Date:  2014-01       Impact factor: 26.132

6.  Ocular Tuberculosis--A Clinical Conundrum.

Authors:  Cecilia Lee; Rupesh Agrawal; Carlos Pavesio
Journal:  Ocul Immunol Inflamm       Date:  2015-06-25       Impact factor: 3.070

Review 7.  Practice Guidelines for Clinical Microbiology Laboratories: Mycobacteria.

Authors:  Betty A Forbes; Geraldine S Hall; Melissa B Miller; Susan M Novak; Marie-Claire Rowlinson; Max Salfinger; Akos Somoskövi; David M Warshauer; Michael L Wilson
Journal:  Clin Microbiol Rev       Date:  2018-01-31       Impact factor: 26.132

Review 8.  Interferon Gamma Release Assays for Latent Tuberculosis: What Are the Sources of Variability?

Authors:  Niaz Banaei; Rajiv L Gaur; Madhukar Pai
Journal:  J Clin Microbiol       Date:  2016-01-13       Impact factor: 5.948

9.  Paradox of serial interferon-gamma release assays: variability width more important than specificity size.

Authors:  J E Stout; R Belknap; Y-J Wu; C S Ho
Journal:  Int J Tuberc Lung Dis       Date:  2018-05-01       Impact factor: 3.427

10.  High Proportion of Indeterminate QuantiFERON-TB Gold In-Tube Results in an Inpatient Population Is Related to Host Factors and Preanalytical Steps.

Authors:  Valeria Fabre; Shmuel Shoham; Kathleen R Page; Maunank Shah
Journal:  Open Forum Infect Dis       Date:  2014-09-19       Impact factor: 3.835

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.